Introduction
While the immune system is equipped to eliminate cancer cells, tumors possess numerous mechanisms by which they diminish anti-tumor immune responses. Defects in T-cell, NK cell and macrophage functions have been demonstrated in patients with solid tumors as well as tumor-bearing mice [7, 8, 11] . One process by which tumors suppress anti-tumor immune responses is by recruiting host cells to become immune suppressive. For example, tumor-associated Wbroblasts (TAF) secrete high levels of the immune suppressant, transforming growth factor-(TGF-) [22] . Tumor-associated macrophages (TAM) represent another cell population that can destroy tumor cells but are instead induced to suppress anti-tumor immune responses by releasing elevated levels of the immune suppressive products, nitric oxide, IL-10 and TGF-, and down-regulating levels of the immune stimulatory product IL-12 [10, 17, 14, 20] . An additional mechanism of tumor-induced immune suppression previously shown by our laboratory is the mobilization of suppressive CD34 + progenitor cells from the bone marrow by tumor secretion of high levels of granulocyte macrophagecolony stimulating factor (GM-CSF). These mobilized CD34 + cells diminish T-cell reactivity through the secretion of TGF- [30] .
In addition to being components of the vasculature, endothelial cells also serve as regulators of immune cell functions. Expression of programmed death-ligand 1 and 2 (PD-L1, PD-L2) by endothelial cells has been shown to down-regulate CD8 + T-cell activation and cytolysis [28] . Endothelial cell expression of PD-L1 induces the generation of CD4 + CD25 + Foxp3 + regulatory T-cells [15] . Liver sinusoidal endothelial cells have the capacity to present antigen from tumor cells and induce tumor-speciWc T-cell tolerance [2] . In addition to suppressing immune cell functions, endothelial cells are capable of stimulating immune cell functions. Co-culture experiments have demonstrated that endothelial cells stimulate IFN-production by CD8
+ T-cells [3] . CD4 + T-cells co-cultured with endothelial cells have been shown to increase T-cell production of IL-2, IL-4 and IFN-in response to PHA stimulation [19] .
While the role of endothelial cells as components of the tumor vasculature has been well studied, their ability to regulate immune cell functions in the tumor microenvironment remains unclear. Endothelial cells can secrete numerous immune suppressive products including vascular endothelial cell growth factor (VEGF), prostaglandin E 2 (PGE 2 ), TGF-, IL-6 and IL-10 [16, 23, 26] . Conversely, they can also secrete the immune stimulatory product IL-12 [18] . The present studies demonstrate that supernatant from endothelial cells pretreated with tumorconditioned medium (Endo T-sup ) diminish NK cell, macrophage and T-cell functions as compared to supernatants from endothelial cells pretreated with either medium (Endo Media ) or with epithelial cell-conditioned medium (Endo Epi-sup ) controls. These studies identify a novel mechanism by which tumors diminish host immune responses by skewing endothelial cells to disrupt NK cell, macrophage and T-cell functions.
Experimental methods

Mice
Eight to twelve week old, female C57BL/6 mice were obtained from Charles River (Wilmington, MA, USA). Mice were housed Wve to a cage with a 12/12 h light dark cycle and fed ad libitum. Mice were humanely euthanized by CO 2 asphyxiation followed by cervical dislocation. Spleens and peritoneal macrophages were then collected and used for immunological analysis. All procedures were conducted with Institutional Animal Care and Use Committee approval.
Cell culture Mouse bEnd.3 endothelial cells, MLE 12 epithelial cells, L929 Wbroblast cells (ATCC, Manassas, VA, USA) and Lewis lung carcinoma (LCC) were maintained in Dulbecco's modiWed Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum, 200 U/ml penicillin G, 200 g/ml streptomycin sulfate, 500 g/ml amphotericin B and 5 £ 10 ¡5 M 2-mercaptoethanol (Sigma-Aldrich, St. Louis, MO, USA). Conditioned medium from MLE 12 mouse lung epithelial cells were used as controls since LLC cells are of lung epithelial cell origin.
Conditioned-media treatment and immune cell isolation
Media alone or 40% supernatants from subconXuent cultures of epithelial cells or LLC cells were used to treat subconXuent cultures of endothelial cells. After 24 h, endothelial cells were washed and fresh DMEM culture medium was added. Twenty-four hours later, endothelial cell-conditioned medium was collected and assayed by ELISA for the presence of immune regulatory products or used to treat freshly isolated immune cell populations.
T-cells were immunomagnetically isolated from the spleens of female C57BL/6 mice. BrieXy, spleens were homogenized into a single cell suspension using a Stomacher 80 Biomaster to obtain a single cell suspension of spleen cells. After lysing red blood cells with ACK lysis buVer, spleen cells were washed three times and resuspended in separation buVer per the immunomagnetic column manufacturer's instructions (Miltenyi Biotech Inc., Auburn, CA, USA). T-cells were isolated using a CD90 + (Thy1.2 + ) immunomagnetic positive selection column. After isolation, T-cells were washed and plated in 96 well, round-bottom plates at a density of 2.5 £ 10 5 cells per well on immobilized anti-CD3. T-cell purity was conWrmed by Xow cytometric analysis of CD3 expression and was determined to be 94% or higher. NK cells were isolated using a negative selection magnetic bead column per the manufacturer's instructions (Miltenyi Biotech Inc.) from the spleens of C57Bl/6 mice. After isolation, NK cells were washed three times and then plated in 96 well, round-bottom plates at a density of 2.5 £ 10 5 cells per well. Both the isolated NK cells and Tcells were maintained in RPMI culture medium with 10% heat-inactivated fetal bovine serum, 200 U/ml penicillin G, 200 g/ml streptomycin sulfate, 500 g/ml amphotericin B, and 5 £ 10 ¡5 M 2-mercaptoethanol. Ten units/ml recombinant mouse IL-2 (R&D Systems, Minneapolis, MN, USA) was added to maintain cell viability. NK cell purity was determined to be 92% or higher as conWrmed by immunostaining for the NK cell marker DX5.
Unstimulated macrophages were isolated from euthanized C57B1/6 mice by peritoneal lavage using 10 ml of ice-cold phosphate buVered saline (PBS). Peritoneal cells were washed, resuspended in phenol-free DMEM culture medium. Macrophages were plated in 24-well plates at a density of 5 £ 10 5 cells per well. After allowing the macrophages to adhere 90 min, they were washed twice to remove non-adherent cells. Macrophage purity was conWrmed by examination of cell morphology, adherence and phagocytic ability.
Immune function assays
After isolation and plating, macrophages, NK cells and T-cells were incubated with either medium alone or 40% Endo Media , Endo Epi-sup or Endo T-sup for 24 h. Cells were washed and new medium was added. After an additional 24 h, supernatants from pretreated immune cells were collected for quantiWcation of protein levels by ELISA and for assessment of immune modulatory eVect as outlined in Endothelial cell and T-cell proliferation was assessed by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) analysis (Promega). MTS is a tetrazolium compound that is reduced to formazan by metabolically active cells and was detected by measuring the absorbance at 492 nm.
In addition to measuring levels of IFN-, IL-10 and TNF-that were secreted by T-cells, intracellular cytokine levels in CD4 + and CD8 + T-cells were measured by Xow cytometry. All Xow cytometry reagents were obtained from BD Biosciences. Prior to surface and intracellular staining, monensin (GolgiStop) was added to T-cells for 2 h according to the CytoStain Kit protocol. Fc II/III receptors were blocked with anti-CD16/CD32 monoclonal antibody. Cell surface antigen staining was performed using anti-CD4 and anti-CD8 monoclonal antibodies. After staining, cells were washed twice, then Wxed and permeabilized with CytoWx/ Cytoperm. Marker channels were set using the antibody isotype controls. Four-color Xow cytometric analysis was performed using BD FACSCanto Flow cytometer with FACS Diva Xow cytometry analysis software.
Macrophage activation was assessed by secretion of TNF-and IL-10 as well as phagocytosis of Xuorescent microbeads. To measure macrophage phagocytosis, 10 l of 1:100 diluted FITC polymer microspheres (Duke ScientiWc Corporation, Palo Alta, CA, USA) were added to macrophages for 4 h at 37°C. Following treatments, the cells were washed three times and resuspended in PBS. To conWrm that bead uptake was a result of phagocytosis, control cells were incubated with beads at 0°C. Following microscopic examination, macrophages were detached from the plates by scraping and bead phagocytosis was quantiWed by Xow cytometric analysis.
Statistical analysis
Statistical analyses was conducted using GraphPad Prism 4.03. ANOVA analysis with post hoc student t test was used to calculate statistical signiWcance between experimental treatment and each of the control treatments. Data 
Results
Endothelial cells treated with tumor-conditioned media secrete increased levels of immune suppressive factors and diminished levels of immune stimulatory factors Endothelial cells secrete numerous immune modulatory factors such as IL-12, VEGF, IL-6, PGE 2 and GM-CSF [18, 16, 23, 26] . Therefore, we examined if exposure to tumorsecreted products alters endothelial cell production of these immune modulators. The immune stimulatory product IL-12 was found to be secreted at lower levels by Endo T-sup than by Endo Media (P = 0.0073) or Endo Epi-sup (P = 0.0028) (Fig. 2a) .
Secretion of immune suppressive products by endothelial cells in response to tumor-conditioned media exposure was also examined. While VEGF has been shown to have numerous pro-angiogenic properties, it has also been shown to inhibit functional dendritic cell maturation and inhibit T-cell development [1, 2] . SigniWcant increases in VEGF secretion were observed in Endo T-sup as compared to Endo Media (P = 0.0051) or Endo Epi-sup (P = 0.0006) (Fig. 2b) . Levels of IL-6 secreted by Endo T-sup were increased as compared to levels secreted by Endo Media or Endo
Epi-sup (P = 0.0008 and P < 0.0001 respectively) (Fig. 2c) . Levels of PGE 2 secreted by Endo T-sup were increased as compared to either Endo Media (P = 0.0044) or Endo Epi-sup controls (P = 0.0025) (Fig. 2d) . Lastly, secretion of the immune modulator GM-CSF was examined. Endo T-sup secreted signiWcantly higher levels than Endo Media or Endo
Epi-sup controls (P = 0.0082 and P = 0.007, respectively) (Fig. 2e) . Endothelial cell secretion of IL-10 was measured and was not aVected by exposure to tumor-conditioned media (Fig. 2f) . Secretion of TGF-was also not altered by treatment with epithelial or tumor conditioned media exposure (data not shown). No signiWcant diVerences were observed in the levels of immune regulatory mediators secreted by Endo Media and Endo Epi-sup control groups, indicating that alterations in secretion were selective to tumor-conditioned media treatment. To conWrm that these results were speciWc to endothelial cells, Wbroblasts were treated with tumorconditioned media or controls and secretion of immune modulatory factors was examined. We observed no signiWcant alterations in Wbroblast secretion of PGE 2 , VEGF, GM-CSF or IL-12 in response to tumor-conditioned medium compared to treatments with medium alone or epithelial cell-conditioned media (data not shown). These results demonstrate that tumor-secreted products induce endothelial cells to increase secretion of immune suppressive products while down-regulating secretion of immune stimulatory products.
Endothelial cell proliferation is increased after exposure to epithelial cell-conditioned media or tumor-conditioned media Endothelial cell proliferation was assessed by MTS after exposure to tumor-conditioned media or control treatments to examine if skewed endothelial cell production of immune modulatory products was inXuenced by their proliferation. Exposure of endothelial cells to epithelial cell-conditioned media and tumor-conditioned medium both increased endothelial cell proliferation (Fig. 3 ) when compared to endothelial cells treated with media alone (P < 0.0001). DiVerences in proliferation between Endo
Epi-sup and Endo T-sup endothelial cells was minimal, but statistically signiWcant (P < 0.0001 After observing that exposure to tumor-conditioned media altered endothelial cell secretion of immune regulatory products, studies were conducted to determine the eVects of endothelial cell-conditioned media on NK cell functions. After isolation, NK cells were incubated with media alone or media conditioned by Endo Media , Endo Epi-sup or Endo T-sup . NK cells were then washed, fresh media added and the cells allowed to incubate for an additional 24 h. Media conditioned by these NK cells was then used to quantitative levels of secreted IFN-and TNF-as a measure of NK cell activation [25] . NK cell exposure to media alone resulted in low or undetectable levels of IFN-and TNF- (Fig. 4a, b) . However, when treated with media conditioned by Endo Media or Endo Epi-sup , NK cell secretion of IFN-and TNF-was signiWcantly increased (P < 0.0001 for both cytokines). However, treatment of NK cells with media conditioned by Endo T-sup resulted in decreased levels of IFN-secretion compared to secretion levels after treatment with media from Endo Media (P = 0.0057) or Endo Epi-sup (P = 0.0006) cells. Similar eVects were observed for TNF-secretion as were seen for IFN-secretion. NK cell secretion of TNFwas signiWcantly increased when exposed to media conditioned by Endo Media or Endo Epi-sup compared to treatment with media alone (P < 0.0001 and P = 0.0005, respectively). NK cells treated with media conditioned by Endo T-sup demonstrated reduced TNF-levels as compared to NK cells treated by conditioned medium from Endo Media or Endo Epi-sup controls (P = 0.0018 and P = 0.0215, respectively).
NK cell secretion of the immune suppressive cytokine, IL-10, following exposure to endothelial cell-conditioned media was also examined. Secretion of IL-10 by NK cells was moderately upregulated following treatment with media conditioned by Endo Media or Endo Epi-sup compared to treatment with media alone. When NK cells were treated with media from Endo T-sup , IL-10 secretion was signiWcantly enhanced compared to NK cells treated with media from Endo Media and Endo Epi-sup controls (P < 0.0001) (Fig. 4c) . These results indicate that endothelial cell-secreted In addition to NK cell studies, the eVects of conditioned medium from Endo T-sup on macrophage functions were also examined. Macrophages were treated for 24 h with medium alone or with Endo Media , Endo Epi-sup or Endo T-sup conditioned media, then washed and allowed to incubate for an additional 24 h. Phagocytosis was measured using a Xuorescent microbead uptake assay and was quantiWed by Xow cytometric analyses. When macrophages were treated with media conditioned by Endo Media or Endo Epi-sup , phagocytosis of Wve or more beads was slightly elevated when compared to macrophages that were incubated in medium alone (Fig. 5) . However, macrophages that were incubated with conditioned medium from Endo T-sup displayed a signiWcant reduction in phagocytosis of Wve or more beads (Fig. 5 ) compared to those treated with control conditioned media (P < 0.0001 for all control groups). Treatment with Endo T-supconditioned medium also reduced total macrophage bead phagocytosis and phagocytosis of two, three or four beads compared to each of the control treatment groups (data not shown).
In addition to phagocytosis, secretion of TNF-and IL-10 was also measured to assess the eVects of endothelial cell-conditioned media on macrophage functions. Treatment with media conditioned by Endo Media or Endo
Epi-sup stimulated macrophage TNF-secretion as compared to that secreted by macrophages treated with medium alone (P < 0.0001 for both controls). Treatment with medium conditioned by Endo T-sup reduced TNF-secretion compared to macrophages treated with conditioned media from Endo Media or Endo Epi-sup (P = 0.002 and P = 0.001 respectively) (Fig. 6a) . Macrophages that were treated in media conditioned by Endo Media or Endo Epi-sup secreted moderately increased levels of IL-10 as compared to treatment with medium alone (P < 0.0001 for both controls) (Fig. 6b) . However, when treated with medium conditioned by Endo T-sup , there was a signiWcant increase in macrophage IL-10 secretion compared to the secretion by all other control treatments (P < 0.0001). These results indicate that tumor-conditioned medium skews endothelial cells to secrete products that suppress macrophage phagocytosis and increase macrophage production of immune suppressive products.
Treatment with medium-conditioned by Endo T-sup diminishes CD8
+ T-cell responses to anti-CD3 stimulation, but does not alter CD4 + T-cell responses
The impact of endothelial cell supernatants on T-cell functions was next examined. CD90 + T-cells were plated on anti-CD3-coated, 96-well plates and treated with medium alone or media conditioned by Endo Media , Endo Epi-sup or Endo T-sup . Flow cytometric analysis demonstrated that when T-cells were treated with Endo T-sup -conditioned medium, there was a signiWcant reduction in the proportion (Fig. 7a-e) . The mean Xuorescent intensity of IFN-+ staining was also reduced in CD8 + T-cells (P < 0.0001) (Fig. 7f) . The percent of CD4 + T-cells that ( Fig. 8a-e) . Mean Xuorescent intensity of IFN-staining by CD4 + T-cells also did not change signiWcantly with any of the endothelial cell-conditioned media treatments (Fig. 8f) .
Total levels of secreted IFN-were also assessed by ELISA to conWrm the alterations in IFN-production that were observed by intracellular cytokine staining. Similar to the intracellular IFN-levels, treatment of T-cells with medium conditioned by Endo T-sup resulted in a signiWcant reduction of IFN-secretion compared to that from T-cells treated with medium only (P < 0.0001), medium conditioned by Endo Media (P = 0.0002) or medium conditioned by Endo
Epi-sup (P < 0.0001) (Fig. 9a) . Levels of TNFsecretion by T-cells were similar among all control treatment groups, but were reduced by half following treatment with Endo T-sup -conditioned medium (P < 0.0001) (Fig. 9b) . When unstimulated T-cells were treated with endothelial cell supernatants, there were no signiWcant diVerence in cytokine production by T-cells that were treated with media conditioned by Endo T-sup or the other control endothelial cell supernatants (data not shown). Also examined were the eVects of endothelial cell conditioned media on T-cell proliferation. Both conditioned medium from Endo Media and Endo Epi-sup increased T-cell proliferation compared to treatment with media alone (P < 0.0001 for both controls) (Fig. 9c) . When T-cells were exposed to media from Endo T-sup , proliferation was diminished compared to medium conditioned by Endo Media (P = 0.0003) and Endo
Epi-sup (P < 0.0001). Levels of T-cell proliferation were similar between T-cells treated with conditioned media from Endo T-sup and media alone. While proliferation levels were similar between media alone conditioned media from Endo T-sup treatment, TNF-and IFN-production was reduced in T-cells treated with conditioned media from Endo T-sup versus media treatment alone (Fig. 9a, b) . These results indicate that tumor-secreted products skew endothelial cells to diminish T-cell activation responses. In addition, Xow cytometric analysis of IFN-production suggests that the suppressive eVects of Endo T-sup -conditioned media may be limited to CD8 + T-cell responses. 
Discussion
Tumors manipulate normal cell populations with in the tumor microenvironment to aid in suppressing anti-tumor immune responses. For example, tumors also secrete products that skew monocytes and dendritic cells to increase production of Th2 cytokines, thereby reducing Th1 anti-tumor reactivity [29] . Tumors selectively recruit CD4 + CD25
+ Foxp3 + cells to suppress tumor-speciWc T-cell responses [4] . Furthermore, tumor-associated macrophages secrete products, such as TGF-and IL-10 that suppress anti-tumor immune responses [14, 20, 10] . Tumor-associated Wbroblasts have also been implicated as suppressors of tumor-associated T-cell functions [22] . While endothelial cells have been shown to be contact-dependent regulators of immune cell functions [5] , few studies have examined their role in modulating immune functions in the tumor microenvironment. We hypothesized that, due to their ability to secrete numerous immune regulatory products, endothelial cells are manipulated by tumors to suppress immune cell functions. In the present studies, we have shown that tumor-secreted products skew endothelial cells to increase production of immune suppressive mediators and disrupt NK cell, T-cell and macrophage functions.
In our in vitro model, it was demonstrated that tumorsecreted products skew endothelial cells to disrupt NK cell, macrophage and T-cell functions. Several endothelial cellderived factors were examined due to their ability to disrupt immune cell functions. While VEGF has been shown to have numerous pro-angiogenic properties, it has also been shown to inhibit T-cell development and is involved in tumor-induced immune suppression [24] . IL-6 was examined due to its ability to inhibit Th1 polarization and promote Th2 diVerentiation of T-cells, thereby diminishing anti-tumor T-cell responses [6] . Lastly, PGE 2 was examined due to its ability to inhibit T-cell functions and down regulate IL-12 production [21, 27] . When endothelial cells were treated with tumor-conditioned media, their production of VEGF-A, IL-6, GM-CSF and PGE 2 increased compared to the levels produced by control endothelial cells. Conversely, endothelial cell secretion of the immune stimulatory product, IL-12, was decreased in response to treatment with tumor-conditioned medium. Analysis of IL-10 and TGF-secretion revealed no signiWcant diVerence in production by endothelial cells that were exposed to tumorconditioned media or control treatments. These studies also demonstrated that tumor-conditioned media skews endothelial cells to diminish T-cell, NK cell and macrophage functions.
Several studies have examined endothelial cells' ability to regulate T-cell functions, though most have focused on contact-dependent regulation. Briscoe et al. demonstrated that co-culture of T-cells with endothelial cells enhances CD4 + T-cell IFN-production in vitro [3] . However, our studies did not demonstrate any alterations in CD4 + T-cell IFN-production following exposure to media from Endo T-sup . One reason for this may be that contact between T-cells and endothelial cells was required in these studies, whereas our model was contact independent. Work by Katz et al. [12] also examined T-cell/endothelial cells interactions using a liver sinusoidal endothelial cell model. Their study observed that endothelial cells alone were insuYcient to stimulate T-cell responses. These studies focused on liver sinusoidal endothelial cells ability to stimulate allogeneic or antigen speciWc T-cell responses, whereas our studies focused on the tumor skewing of endothelial cells to disrupt T-cells responses to anti-CD3 stimulation. Our studies did not investigate the eVects of tumor skewing on endothelial cell presentation of antigen to stimulate T-cell responses.
Previous studies focusing on endothelial cell modulation of NK cell and macrophage functions have predominantly examined contact-dependent regulation. Limited work has focused on contact-independent activation of NK cells by endothelial cells. Endothelial cell and monocyte/macrophage interactions have also been investigated including studies focusing on post-hemorrhagic vasospasm, Mycobacterium leprae and other physiological responses involving inXammation [1, 9, 13] . The majority of this work has focused on endothelial cell expression of adhesion molecules and their eVects on macrophage functions. These studies did not, however, examine the immune regulatory eVects of endothelial cells in the tumor microenvironment. Studies are currently ongoing to determine what factor(s), including IL-12 and IL-12 family members, are responsible for endothelial cell modulation of NK cell functions.
The studies presented here demonstrate that normal endothelial cells have immune stimulatory eVects, whereas tumor-skewed endothelial cells suppress these stimulatory eVects. This is analogous to the Th1 and Th2 balance which is skewed toward Th2 in tumor-bearers. By analogy, tumorexposed endothelial cells could be termed to have an E2 phenotype as compared to epithelial cell-exposed endothelial cells, which could be termed to have an E1 phenotype. One area not addressed by these studies is whether antitumor immune responses are suppressed by tumor-exposed endothelial cells. Studies are currently ongoing to assess the eVects of endothelial cells in suppressing NK cell and T-cell reactivity against tumor cells. Studies are also currently underway to determine the tumor-secreted factor(s) responsible for skewing endothelial cells toward an E2 phenotype. Another question that remains to be answered is how tumor-exposed endothelial cells are disrupting 
